Edwin W Mclaughlin Iii, MD | |
4092 Foxwood Dr, Virginia Beach, VA 23462-5225 | |
(757) 467-4200 | |
Not Available |
Full Name | Edwin W Mclaughlin Iii |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 28 Years |
Location | 4092 Foxwood Dr, Virginia Beach, Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669401550 | NPI | - | NPPES |
5839068 | Medicaid | VA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 0101056456 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Sentara Virginia Beach General Hospital | Virginia beach, VA | Hospital |
Sentara Princess Anne Hospital | Virginia beach, VA | Hospital |
Sentara Leigh Hospital | Norfolk, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Emergency Physicians Of Tidewater | 5092618462 | 150 |
News Archive
The 11th Annual AACR International Conference on Frontiers in Cancer Prevention Research will bring together scientists, survivors and patient advocates to share the latest science on cancer prevention.
Zogenix, Inc. and Desitin Pharmaceuticals GmbH today announced that the Danish Medicines Agency of Denmark has approved the Marketing Authorization Application (MAA) for SUMAVEL® DosePro™ (sumatriptan injection) Needle-Free Delivery System. Denmark is the first country in Europe to grant marketing authorization for SUMAVEL DosePro for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for review the Biologics License Application (BLA) for MK-3475, Merck's investigational anti-PD-1 antibody, for the treatment of unresectable or metastatic melanoma in patients who have been previously treated with ipilimumab.
Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has launched an over-the-counter (OTC) pain reliever, Cobroxin, for the treatment of Stage 2 (moderate to severe) chronic pain.
› Verified 6 days ago
Entity Name | Emergency Physicians Of Tidewater |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033136841 PECOS PAC ID: 5092618462 Enrollment ID: O20040202000195 |
News Archive
The 11th Annual AACR International Conference on Frontiers in Cancer Prevention Research will bring together scientists, survivors and patient advocates to share the latest science on cancer prevention.
Zogenix, Inc. and Desitin Pharmaceuticals GmbH today announced that the Danish Medicines Agency of Denmark has approved the Marketing Authorization Application (MAA) for SUMAVEL® DosePro™ (sumatriptan injection) Needle-Free Delivery System. Denmark is the first country in Europe to grant marketing authorization for SUMAVEL DosePro for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for review the Biologics License Application (BLA) for MK-3475, Merck's investigational anti-PD-1 antibody, for the treatment of unresectable or metastatic melanoma in patients who have been previously treated with ipilimumab.
Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has launched an over-the-counter (OTC) pain reliever, Cobroxin, for the treatment of Stage 2 (moderate to severe) chronic pain.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Edwin W Mclaughlin Iii, MD Po Box 7549, Portsmouth, VA 23707-0549 Ph: (757) 686-3508 | Edwin W Mclaughlin Iii, MD 4092 Foxwood Dr, Virginia Beach, VA 23462-5225 Ph: (757) 467-4200 |
News Archive
The 11th Annual AACR International Conference on Frontiers in Cancer Prevention Research will bring together scientists, survivors and patient advocates to share the latest science on cancer prevention.
Zogenix, Inc. and Desitin Pharmaceuticals GmbH today announced that the Danish Medicines Agency of Denmark has approved the Marketing Authorization Application (MAA) for SUMAVEL® DosePro™ (sumatriptan injection) Needle-Free Delivery System. Denmark is the first country in Europe to grant marketing authorization for SUMAVEL DosePro for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for review the Biologics License Application (BLA) for MK-3475, Merck's investigational anti-PD-1 antibody, for the treatment of unresectable or metastatic melanoma in patients who have been previously treated with ipilimumab.
Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has launched an over-the-counter (OTC) pain reliever, Cobroxin, for the treatment of Stage 2 (moderate to severe) chronic pain.
› Verified 6 days ago
Ioliene Boenau, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3914 W Stratford Rd, Virginia Beach, VA 23455 Phone: 757-460-5924 | |
Moss H Mendelson, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 4092 Foxwood Dr, Suite 101, Virginia Beach, VA 23462 Phone: 757-467-4200 | |
Anthony C Cetrone, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6632 Indian River Rd, Virginia Beach, VA 23464 Phone: 757-424-4300 Fax: 757-523-0632 | |
Dr. Natalie Sobota Feldman, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4092 Foxwood Dr, Ste 101, Virginia Beach, VA 23462 Phone: 757-686-3508 Fax: 757-686-0541 | |
Christopher L Gibert, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4092 Foxwood Dr, Suite 101, Virginia Beach, VA 23462 Phone: 757-467-4200 | |
Dr. Andy Cameron Bunch, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4092 Foxwood Dr Ste 101, Virginia Beach, VA 23462 Phone: 757-467-4200 | |
Beverly Nyokabi, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4445 Corporation Ln Ste 264, Virginia Beach, VA 23462 Phone: 540-776-4028 |